PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.45%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-33.23%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-87.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-93.30%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-80.99%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-79.07%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-79.07%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.76%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.28%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
9.57%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
6.27%
OCF growth under 50% of NXPI's 37.88%. Michael Burry might suspect questionable revenue recognition or rising costs.
21.75%
FCF growth under 50% of NXPI's 94.26%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
121.43%
10Y revenue/share CAGR above 1.5x NXPI's 79.10%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
81.93%
5Y revenue/share CAGR similar to NXPI's 77.31%. Walter Schloss might see both companies benefiting from the same mid-term trends.
-13.17%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
367.14%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
111.98%
5Y OCF/share CAGR is similar to NXPI's 107.18%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
54.17%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
0.30%
Below 50% of NXPI's 36.73%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-57.80%
Negative 5Y net income/share CAGR while NXPI is 328.95%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-79.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
153.14%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
59.03%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-2.17%
Negative 3Y equity/share growth while NXPI is at 42.98%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
656.97%
Dividend/share CAGR of 656.97% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
692.36%
5Y dividend/share CAGR above 1.5x NXPI's 169.49%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
267.82%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-48.53%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-12.70%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-4.36%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.95%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-14.99%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.